Featured Article
Academic Journal
Main Category: Fertility
Also Included In: Genetics;Â Â Men's Health
Article Date: 25 May 2012 - 2:00 PDT
Patient / Public:
The discovery of a gene that enables sperm to mature may lead to the development of a non-hormonal male contraceptive, according to new research in mice, led by the University of Edinburgh, Scotland, that was published in the journal PLoS Genetics on 24 May.
Currently, the only male contraceptives available rely on disrupting the production of hormones like testosterone, which can cause unpleasant side effects such as acne, irritability and mood swings.
First author Dr Lee Smith is Reader in Genetic Endocrinology at the University of Edinburgh's Centre for Reproductive Health. He told the media:
"If we can find a way to target this gene in the testes, we could potentially develop a non-hormonal contraceptive."
The gene, called Katnal1, is critical to enabling sperm to mature in the testes.
Finding a way to regulate the gene could potentially stop the sperm maturing and render them ineffective.
Not only could this form the basis of a new type of male contraceptive that does not involve disrupting hormone levels, it could also lead to new treatments for male infertility caused by a faulty Katnal1 gene.
"The important thing is that the effects of such a drug would be reversible because Katnal1 only affects sperm cells in the later stages of development, so it would not hinder the early stages of sperm production and the overall ability to produce sperm," explained Smith.
"Although other research is being carried out into non-hormonal male contraceptives, identification of a gene that controls sperm production in the way Katnal1 does is a unique and significant step forward in our understanding of testis biology," he added.
The production and maturation of sperm cells is a complex process that relies on key interactions between germ cells and supporting mechanisms, including a "scaffolding" structure made of microtubules that allows nutrients and other compounds essential to sperm health and growth to travel to the germ cells.
The authors write that it is well established that an essential component of male fertility is a process that breaks down and rebuilds the microtubules, which allows the sperm cells to move within the testes as they mature.
But until now, nobody knew which gene was responsible for this process.
In their study, Smith and colleagues discovered that when they knocked out the Katnal1 gene in male mice it rendered them infertile.
They found that Katnal1 is expressed in the testicular Sertoli cells (SC) that support germ cell maturation and that "consistent with chemical disruption models, loss of function of KATNAL1 leads to male-specific infertility through disruption of SC microtubule dynamics and premature exfoliation of spermatids from the seminiferous epithelium".
Thus they established that Katnal1 is the essential controller of the process that regulates the microtubule scaffolding structure.
In their discussion, Smith and colleagues describe Katnal1 as an essential promoter of male fertility, and discovering how it behaves within the testicular Sertoli cells "represents an important first step towards understanding the molecular mechanisms underlying SC microtubule remodelling".
"Such information will be of utility both for increasing our understanding of male infertility and the development of treatments and non-hormonal male contraceptives," they conclude.
Grants from the UK Medical Research Council and the National Health and Medical Research Council of Australia helped finance the study.
Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today
- Additional
- References
- Citations
Additional source: Public Library of Science Please use one of the following formats to cite this article in your essay, paper or report:
MLA
APA
Please note: If no author information is provided, the source is cited instead.
Visitor Opinions (latest shown first)
The Ratio of DHEA and Testosterone may Control Sperm Maturation via KATNAL1
posted by James Michael Howard on 25 May 2012 at 4:36 amIt is my hypothesis that evolution selected dehydroepiandrosterone (DHEA) because it optimizes replication and transcription of DNA. Therefore DHEA levels affect all cells and tissues. DHEA naturally begins to decline around the ages of twenty to twenty-five, reaching very low levels in old age.
It is also my hypothesis that testosterone evolved to increase DHEA entrance into cells where it stimulates gene activity. That is, testosterone increases androgen receptors through DHEA enters cells. Testosterone and DHEA reach an optimal ratio during the life span which is directly involved in reproduction, therefore, overall health.
Since DHEA and testosterone both decline in ageing, then the stimulatory activity of DHEA declines significantly with age.
The findings of Smith, et al., that KATNAL1 is involved in sperm maturation produce a useful hypothesis regarding the effects of sperm from older men. Abnormal sperm characteristics are common in elderly m en as well as mental disorders in their offspring. "Progenies of fathers under 20 and over 50 had higher risk for mental disorders. Factors such as immaturity in sperm of teenage fathers, mutation in germ line of older fathers, environmental and psychosocial factors could have contributed to increased prevalence of common mental disorders in the progeny." (World J Biol Psychiatry. 2009;10(4 Pt 2):518-23)
I suggest that low DHEA is involved in reduced maturation of sperm. Since testosterone and DHEA combine to increase gene activity, young men may not produce an optimal ratio of testosterone and DHEA to produce sufficiently mature sperm, that is, their testosterone may be too low. Older men, as stated above, do not produce sufficient DHEA and testosterone to produce mature sperm. It may be that lack of sperm maturation produces both the infertility of elderly men as well as the "higher risk for mental disorders" of the offspring of elderly and young men.
| post followup | alert a moderator |
Add Your Opinion On This Article
'Sperm Gene Discovery May Lead To Non-Hormonal Male Contraceptive'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy | Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
Tidak ada komentar:
Posting Komentar